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Summary 
The flip and flop splice variants of AMPA receptors 
show strikingly different sensitivity to allosteric regu- 
lation by cyclothiazide; heteromers assembled from 
GluR-A and GluR-B also exhibit splice variant-depen- 
dent differences in efficacy for activation by glutamate 
and kainate. The sensitivity for attenuation of desensi- 
tization by cyclothiazide for homomeric GluR-A was 
solely dependent upon exchange of Set-750 (flip) and 
Asn-750 (flop), and was unaffected by mutagenesis 
of other divergent residues. In contrast, substantial 
alteration of the relative efficacy of glutamate versus 
kainate required mutation of multiple residues in the 
flip/flop region. Modulation by cyclothiazide was abol- 
ished by mutation of Ser-750 to Gin, the residue found 
at the homologous site in kainate-preferring subunits, 
whereas introduction of Ser at this site in GluR6 im- 
parted sensitivity to cyclothiazide. 
Introduction 
AMPA (~-amino-3-hydroxy-5-methyl-4-isoxazole propionic 
acid) receptors, which mediate fast excitatory responses 
at the majority of CNS synapses (Trussell et al., 1994; 
Collingridge and Lester, 1989), show considerable hetero- 
geneity in their functional properties (Livsey and Vicini, 
1992; Hestrin, 1993; McBain and Dingledine, 1993; Jonas 
et al., 1994; Raman et al., 1994), most likely as a result 
of alternative splicing (Sommer et al., 1990; Gallo et al., 
1992; KGhler et al., 1994), RNA editing (Sommer et al., 
1991; Lomeli et al., 1994), and assembly of heteromers 
from various members of the AMPA receptor gene family 
(Boulter et al., 1990; Kein~.nen et al., 1990; Mosbacher et 
al., 1994). Studies on the alternatively spliced forms of 
AMPA receptor subunits named flip and flop, which are 
generated by alternative usage of two exons each encod- 
ing 38 amino acids (Sommer et al., 1990), have revealed 
marked differences in sensitivity to allosteric regulation 
of desensitization by cyclothiazide (Partin et al., 1994). 
Whether the differential regulation by cyclothiazide is due 
to an interaction between the drug and receptor at amino 
acids encoded by the flip/flop module, or whether these 
residues direct a conformational change that affects drug 
interaction at a distal site, is not known. The discovery 
that drugs which reduce AMPA receptor desensitization 
also modulate fast excitatory synaptic transmission (Isaac- 
son and Nicoll, 1991; Vyklicky et al., 1991; Yamada and 
Rothman, 1992; Yamada and Tang, 1993) and enhance 
performance in animal models of learning (Staubli et al., 
1994; Nicoletti et al., 1992) provides further stimulus for 
understanding the molecular mechanisms underlying the 
differential sensitivity of AMPA receptor splice variants to 
allosteric regulation by cyclothiazide. 
To address this issue, we have performed site-directed 
mutagenesis, exchanging amino acids in each of the three 
regions that differ between the flip and flop splice variants 
of AMPA receptors and expressing the mutant receptors 
either in Xenopus laevis oocytes or transiently transfected 
293 cells, using as an assay each of the multiple changes 
in AMPA receptor activity that occur owing to allosteric 
modulation by cyclothiazide (Partin et al., 1994). In addi- 
tion, we analyzed the same mutations for their effect on 
the relative efficacy of glutamate and kainate as agonists. 
This is of interest because it is thought hat for A,opB,op the 
lower amplitude of steady state responses to glutamate 
compared with kainate reflects stronger desensitization 
for this subunit combination than for A,~pBfHp (Sommer et al., 
1990; Mosbacher et al., 1994; Partin et al., 1994; Lomeli et 
al., 1994). Our results show that the molecular determinant 
critical for allosteric regulation by cyclothiazide is neces- 
sary but insufficient o regulate the efficacy of glutamate 
versus kainate without he exchange of additional residues 
in the flip/flop module. 
Results 
Mutational Strategy 
Alignment of the two 38 amino acid regions encoded by 
exons for the flip and flop modules (Figure 1) shows three 
distinct regions of heterogeneity, separated by regions of 
amino acid identity (Sommer et al., 1990). The first region 
of heterogeneity is at the N-terminal boundary of the alter- 
natively spliced region and therefore is juxtaposed next 
to the RNA editing site in GluR-B, GluR-C, and GluR-D 
(Lomeli et al., 1994): in these subunits the first pair of 
residues for the flip isoforms is ThrPro, whereas in the 
flop isoforms the sequence is AsnAla; in GluR-A the corre- 
sponding sequences are GlyPro and AsnPro. The second 
region lies 10 residues away from the Thr/Asn site and 
consists of a single amino acid difference, Ser for the flip 
isoforms and Asn for the flop isoforms. The third region 
of heterogeneity lies close to the C-terminal boundary of 
the alternatively spliced region and consists of 4 consecu- 
tive residues, LysAspSerGly for flip isoforms and GlyGly- 
GlyAsp for flop. 
Our mutational strategy to define the amino acids that 
are critical for allosteric modulation by cyclothiazide was 
to make single amino acid substitutions, converting flip (i) 
residues to flop (o) residues and vice versa. Point muta- 
tions are referred to using the conventional single letter 
nomenclature, e.g., AiS750N and AoN750S (Figure 1). Be- 
cause our initial experiments with point mutations in the 
C-terminal boundary did not influence modulation by 
cyclothiazide, we then constructed mutations that con- 
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Figure 1. Sequence Alignment and Mutants of the Flip/Flop Domain 
and Homologous Region in Kainate Receptors 
(A) Alignments for the flip and flop versions of GluR-A (residues 739- 
777 of the mature polypeptide) and GluR-8 (residues 743-781), and 
for the kainate receptor subunits GluR5-7, KA1, and KA2. Asterisks 
above the alignment indicate positions at which mutations were intro- 
duced; a plus sign indicates an RNA editing site. Shaded residues 
indicate three regions of heterogeneity between AM'PA'receptor splice 
variants: TP-S-KDSG for flip and NA-N-GGGD for flop, except hat for 
GluR-A the first pair of conserved amino acids differs from those for 
other subunits. For kainate receptor subunits there is a glutam ne 
(Q755 in GluR6] at the position corresponding to the serine/asparagine' 
site in AMPA receptors. - ' " ° 
(B) Schematic of the flip/flop module for the mutants constructed for the 
present experiments, with each mutant identified by the abbreviatio0s 
shown on the left; boxes indicate the residues introduced by,site- 
directed mutagenesis and their location in the f p/flop module 
verted all 4 amino acids in this region. These mutations 
are referred to as A [io] or Ao[oi], where the first letter in 
brackets designates the Ser/Asn site and the second letter 
refers to the four residues near the C-terminus of the alter- 
natively spliced region. Combined mutations that altered 
both the Ser/Asn site and ~the4 residues are referred to 
as Ai[oo] and Ao[ii], The additional mutation in Ao[ii] to the 
flip form of a single amino acid difference at the N-terminal 
boundary of the flip/flop module (position 740: asparagine 
to glycine) is referred to as Ao[iii]. The nomenclature used 
for comparable GluR-B mutants is similar to that for GluR-A, 
with the exception that the construction of Bo[iii] from Bo[ii] 
required the additional exchange of 2 amino acids at posi- 
tions 744 and 745 from their flop (AsnAla) to their flip 
(ThrPro) forms, GluR-Bo mutants were assayed in combi- 
nation with wild-type and mutant GluR-Ao subunits, be- 
cause hom0meric receptors generated from GluR-B ex- 
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Figure 2. Modulation of Desensitization by Cyclothiazide for the Flip 
and Flop Versions of Homomeric AMPA Receptors Is Controlled by 
a Single Amino Acid 
(A and B) The left-hand pairs of traces show responses to 1 mM gluta- 
mate (closed bars) before and during application of 100 p,M cyclothia- 
zide (open bars). The right-hand pairs of traces show comparable re- 
sponses for mutants in which a single amino acid was exchanged from 
its flip (serine) to its flop (asparagine) form and vice versa. Control 
responsesto glutamate are shown on a 4-times expanded time scale 
and are normalized to the peak amplitude of responses recorded in 
the presence of cyclothiazide. 
(C) Responses for mutants in which a set of 4 conserved amino acids 
was exchanged from the flip (KDSG) to the flop (GGGD) form and vice 
versa. 
(D and E) Summaries of equilibrium desensitization and potentiation 
of responses to 1 mM glutamate, both recorded in the presence of 
100 ~M cyclothiazide for 5-7 cells per subunit (bars show mean 
SEM). Experiments were performed using whole-cell recording from 
293 cells with agonists applied by concentration jump. 
press very small currents (Boulter et al., 1990; Herlitze et 
al., 1993). 
Prior studies with wild-type AMPA receptors assembled 
from GluR-A and GluR-B have revealed a variety of func- 
tional differences between flip and flop splice variants, 
including the extent of attenuation of desensitization of 
responses to glutamate by cyclothiazide, the potency for 
potentiation of responses to kainate by cyclothiazide, the 
kinetics of recovery from potentiation by cyclothiazide, 
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the presence or absence of cyclothiazide-evoked shifts in 
the kainate dose-response curve, and the differences in 
agonist efficacy as determined by the relative amplitude 
of equilibrium responses to kainate versus glutamate 
(Sommer et al., 1990; Partin et al., 1994). Selected mutant 
AMPA receptors were assayed for each of these parame- 
ters, as well as for desensitization of control responses to 
glutamate applied by rapid perfusion. 
A Single Amino Acid Controls Block of 
Desensitization by Cyclothiazide 
Similar to wild-type recombinant AMPA receptors (Mos- 
bacher et al., 1994; Partin et al., 1994), homomeric recep- 
tors assembled from the GluR-A mutants generated for 
this study all showed pronounced desensitization in re- 
sponse to 1 mM glutamate (Figure 2). In 293 cells transfected 
with mutant AM PA receptors, the rate of onset of desensiti- 
zation was rapid (time constant typically < 5 ms) and not 
significantly different for the various mutants examined 
(Table 1); the extent and kinetics of onset of desensitiza- 
tion were also indistinguishable from results obtained for 
wild-type GluR-A~ and GluR-Ao (Partin et al., 1994; Mos- 
bacher et al., 1994). In the presence of 100 I~M cyctothia- 
zide, desensitization was strikingly reduced for AoN750S 
and A~[io], with results similar to those obtained for wild- 
type GluR-A~ (Partin et al., 1994). For A~S750N and Ao[oi], 
the rate of onset of desensitization was slowed approxi- 
mately 50-fold in the presence of 100 p.M cyclothiazide 
(time constant typically > 200 ms; Table 1), but at equilib- 
rium the extent of desensitization remained pronounced 
(Figure 2), similar to the behavior obtained for wild-type 
GluR-Ao. Such experiments indicate that, for homomeric 
AMPA receptors assembled from GluR-Ai, the marked at- 
tenuation of desensitization by cyclothiazide requires a 
serine residue at position 750, with no difference in behav- 
ior when the C-terminal set of 4 conserved amino acids 
is in the flip or flop form. Conversely, in GluR-Ao the pres- 
ence of an asparagine residue at position 750 is sufficient 
to produce a 50-fold slowing in the rate of onset of desensi- 
tization in the presence of cyclothiazide (Table 1), with no 
effect observed on exchange of the C-terminal set of 4 
amino acids to the flip form (Figure 2). 
Recovery from Potentiation by Cyclothiazide 
A second striking difference in the effect of cyclothiazide 
on wild-type AMPA receptor flip and flop splice variants 
was observed upon analysis of the kinetics of recovery 
from potentiation of responses to kainate; recovery is 
extremely slow for GluR-Ai but rapid for GluR-Ao, consis- 
tent with the higher apparent affinity of cyclothiazide for 
GluR-Ai (Partin et al., 1994). To examine the influence of 
amino acids conserved in flip versus flop splice variants 
on recovery from potentiation, we recorded the effect of 
brief applications of 100 I~M cyclothiazide on responses to 
1 mM kainate using Xenopus oocytes expressing mutant 
AMPA receptors (Figure 3). Recovery from potentiation 
was slow for AoN750S and for A~[io], with close to 100 s 
typically required for 63% recovery, similar to results ob- 
tained for wild-type GluR-A~ (Table 1). For A~S750N and 
Ao[oi], the potentiating effect of cyclothiazide was rapidly 
reversible; 5 s or less was typically required for 63% recov- 
ery, similar to results obtained for wild-type GluR-Ao (Table 
1). Thus, identical to the requirements for attenuation of 
desensitization by cyclothiazide, slow recovery from po- 
tentiation of responses to kainate also requires a serine 
residue at position 750, with no influence of the C-terminal 
set of 4 amino acids. Conversely, introduction of an aspar- 
agine residue at position 750 increases the rate of recovery 
from potentiation by cyclothiazide, irrespective of whether 
the C-terminal set of 4 conserved amino acids is in the 
flip (KDSG) or flop (GGGD) version. 
Dose-Response Analysis for Responses to 
Cyclothiazide and to Kainate 
For wild-type AMPA receptors, the concentration of 
cyclothiazide required for half-maximal potentiation of 
responses to kainate is approximately 9-fold lower for 
GluR-A~ than for GluR-Ao (Partin et al., 1994). To determine 
A GluR-Ai wt 
100 pM Cyclo 
B 
GluR-Ao wt N750S 
C 
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d~ 
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'/ 
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Figure 3. In Homomeric AMPA Receptors, Recovery from Potentia- 
tion by Cyclothiazide Is Controlled by the Same Site Regulating Alloste- 
ric Modulation of Desensitization 
(A and B) Potentiation of responses to 0.3 mM kainate (closed bars) 
during application of 100 pM cyclothiazide (open bars) for wild-type 
receptors (left) and for mutants in which either the single residue at 
position 750 (middle) or the C-terminal set of 4 amino acids (right) was 
exchanged from the flip to the flop form and vice versa. Following 
removal of cyclothiazide, there is a transient increase in amplitude of 
responses to kainate before the onset of the decay of potentiation; 
this results primarily from rapid recovery from an inhibitory effect of 
cyclothiazide itself, which does not distinguish between splice vari- 
ants, and thus is probably not determined by the flip/flop module. 
(C and D) Summaries of measurements of the time required for 630/0 
recovery from potentiation by cyciothiazide for wild-type and mutant 
receptors (bars show mean _+ SEM, with the number of oocytes tested 
indicated above each plot). Experiments were performed using two- 
electrode voltage-clamp recording from Xenopus oocytes. 
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Figure 4. Cyclothiazide and Kainate Dose- 
Response Analysis for Mutants 
Dose-response analysis for the potentiating ef- 
fects of cyclothiazide in homomeric AMPA re- 
ceptors reveals regulation by the residue at po- 
sition 750, but not by the C-terminal residues 
in the flip/flop module. 
(A and B) Dose-response curves for potentia- 
tion of responses to 300 p.M kainate by cyclothi- 
azide. Similar to the difference observed for 
wild-type GluR-A,~p versus wild-type GluR-A,op, 
the potency of cyclothiazide is higher for poten- 
tiation of responses for AoN750S and Ai[io] than 
for A~S750N and Ao[oi]. Data points show mean 
- SEM of observations from 4-8 oocytes per 
subunit. For the analysis shown in (A), data 
points at 300 #M cyclothiazide were excluded 
from the fit due to a reduction in potentiation 
resulting from inhibition at high concentrations 
of cyclothiazide; in these experiments, DMSO 
(1.5%) was present in all solutions. 
(C and D) Dose-response curves for control 
responses to kainate (dashed lines); in the 
presence of 100 p.M cyclothiazide (solid lines), 
there is a leftward shift for AoN750S and A~[io] 
but not for A~S750N and Ao[oi]. 
whether the amino acids that regulate attenuation of de- 
sensitization by cyclothiazide also control sensitivity to 
cyclothiazide, dose-response curves were recorded in 
Xenopus oocytes expressing mutant AMPA receptors 
(Figures 4A and 4B). Such experiments revealed that the 
greater potency of cyclothiazide for potentiation of re- 
sponses to kainate for GluR-A, versus GluR-Ao requires 
the same amino acid residue at position 750 that regulates 
block of desensitization. Thus, similar to wild-type GluAi, 
the potency of cyclothiazide was high for AoN750S and 
A~[io] but low for A~S750N and Ao[oi]. Together, these re- 
sults reveal no effect of the C-terminal set of 4 conserved 
amino acids, with the potency of cyclothiazide determined 
exclusively by the presence of a serine or asparagine resi- 
due at position 750 (Table 1). 
Analysis of the effects of cyclothiazide on kainate dose- 
response curves (Figures 4C and 4D) revealed a shift to 
the left by 100 I~M cyclothiazide of 7-fold for AoN750S and 
6-fold for A~[io], similar to the 5-fold shift seen for wild-type 
GluR-A~, with no effect of cyclothiazide on the potency of 
kainate for A~S750N and Ao[oi]. Together with previous 
results for block of desensitization, these experiments re- 
veal a single amino acid switch between the flip and flop 
versions of Glu R-A to be sufficient o determine each com- 
ponent of allosteric modulation by cyclothiazide assayed 
in the present experiments, most likely indicating a com- 
mon mechanism of action. 
Sensitivity to Cyclothiazide in Homomeric AMPA 
and Kainate Receptors Regulated by a Glutamine 
Residue Conserved in Kainate Receptor Subunits 
The regulation of sensitivity to cyclothiazide for the flip 
and flop versions of GluR-A by a single amino acid, and 
considerable sequence homology between AMPA and kai- 
nate receptors in this region (Figure 1), raised the possibil- 
ity that the lack of sensitivity of kainate receptors to cyclo- 
thiazide (Partin et al., 1993; Wong and Mayer, 1993) might 
reflect sequence differences between AMPA and kainate 
receptors over this region. Within 11 amino acids sur- 
rounding the Ser/Asn site in AMPA receptors, sequence 
alignments for each of the five known kainate receptor 
subunits reveal 6-7 residues to be identical or to have 
highly conservative substitutions. In AMPA receptors 9/11 
residues are identical over the same region; however, at 
the position corresponding to the Ser/Asn site in AMPA 
receptors, all five kainate receptor subunits express a glu- 
tamine residue (Figure 1). 
Substitution of a glutamine at position 750 in both 
AtS750Q and AoN750Q essentially abolished sensitivity to 
cyclothiazide (Figure 5A), without altering agonist potency 
(Figure 5B). The absence of potentiation of responses to 
kainate and glutamate by cyclothiazide was particularly 
striking for the response of A~S750Q to 300 ~M glutamate 
(100 I~M cyclothiazide/control = 0.996 _+ 0.082; n = 11), 
since for wild-type GluR-Ai there was a 157 _ 52-fold 
potentiation (n -- 6). The cyclothiazide-evoked shift in ECs0 
for activation by kainate was also abolished for A~S750Q 
(Figure 5B). In both the presence and absence of cyclothia- 
zide, the potency of kainate was similar to control values 
obtained for wild-type GluR-A~ and for other mutant recep- 
tors (Table 1), indicating that although the introduction of 
Gin-750 is sufficient o abolish sensitivity to cyclothiazide, 
it does not confer the high sensitivity to kainate typical 
of wild-type kainate receptors, and that is seen in AMPA 
receptor chimeras containing kainate receptor sequences 
thought to encode the agonist-binding site (Stern-Bach et 
al., 1994). Consistent with these results, when assayed 
in 293 cells, cyclothiazide failed to block desensitization 
for both A~S750Q and AoN750Q (Figure 5C). The rate of 
onset of and the extent of desensitization for control re- 
sponses to 1 mM glutamate in 293 cells transfected with 
these Gin-750 mutants were similar to values obtained 
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Figure 5. SensitivitytoCyclothiazideBIockedbyaGlutamineResidue 
in Homomerie AMPA and Kainate Receptors 
(A) Responses to 0.3 mM kainate and 0.3 mM glutamate recorded 
from a Xenopus oocyte expressing AiS750Q, before and during appli- 
cation of 100 p_M cyclothiazide. In contrast o results obtained for wild- 
type GluR-Ai, cyclothiazide fails to produce a clear potentiation of re- 
sponses to either agonist; this is particularly striking in the case of 
glutamate, for which potentiation would normally be greater than 
150-fold. 
(B) Analysis of kainate dose-response curves recorded from Xenopus 
oocytes expressing AiS750Q in the presence (n = 5) and absence 
(n = 6) of 100 I~M cyclothiazide. Data points show mean _+ SEM fit 
with a logistic equation, which gave ECsos for kainate of 40.1 and 38.0 
p.M before and du ring application of cyclothiazide. In contrast o results 
obtained for wi.ld-type GluR-Ai, there was no leftward shift in the dose- 
response curve in the presence of cyolothiazide. 
((3) Responses to 1 mM glutamate (closed bars) before and during 
application of 100 p M cyclothiazide (open bar) for a 293 cell transfected 
with A~S750Q; lines fit to the desensitizing component phase are single 
exponential functions. In contrast to results obtained for wild4ype 
GluR-A~, cyclothiazide has no significant effect on the extent (control, 
98.4°/0; cyclothiazide, 97.30/o) or rate of onset of desensitization (con- 
trol • de,, 2.2 ms; cyclothiazide tdes, 3.8 ms); similar esults were obtained 
for AoN750Q. 
(D) Responses to 1 mM kainate (closed bars) before and during appli- 
cation of 100 I~M cyclothiazide (open bar) for a 293 cell transfected 
with GluR6Q755S; lines fit to the desensitizing phase are double expo- 
nential functions. In contrast to the complete lack of sensitivity to 
cyclothiazide observed for wild-type GluR6, for GluR6Q755S there 
was a clear reduction in the rate of onset of desensitization (63% decay 
times: control, 25.3 ms; cyclothiazide, 55.5 ms), although for kainate 
applications 1.5 s in duration, the extent of desensitization was similar 
in the presence (88.40/0) and absence (89.1%) of cyclothiazide. 
for both wild-type AMPA receptors and the other mutants 
constructed for this study, and was unaltered in the pres- 
ence of cyclothiazide (Table 1). Together, these results 
indicate that the lack of sensitivity to cyclothiazide was not 
a result of a loss of desensitization for control responses to 
glutamate. 
The block of AMPA receptor sensitivity to cyclothiazide 
by introduction of a glutamine residue at position 750, and 
sequence homology between AMPA and kainate recep- 
tors at positions surrounding this site, suggests that the 
absence of kainate receptor sensitivity to cyclothiazide 
might arise from the presence of a glutamine residue in 
kainate receptor subunits. To examine this possibility, we 
constructed the mutant GluR6Q755S. In contrast to re- 
sults obtained for the AMPA receptor mutant A~S750Q, 
the desensitization kinetics of control responses to 1 mM 
kainate for GluR6Q755S were not identical to those for 
wild-type GluR6, with GluR6Q755S showing a reduced 
rate of onset of desensitization (wild type: Tldes= 9.6 ± 
1.0 ms, A1 -- 93.30/0 _ 1.6O/o, "~2des -- 156 --. 27 ms; 
GluR6Q755S: "qdes = 29.6 - 2.4 ms, A1 = 84.80/0 ± 
1.4%, ~2~es = 318 _ 39 ms). In addition, there was less 
desensitization for GluR6Q755S (90.6% ± 1.6%) than 
for wild-type Glu R6 (97.8% _+ 0.6% ). However, in contrast 
to the cyclothiazide-insensitive responses obtained for 
wild-type GluR6, the rate of onset of desensitization for 
GluR6Q755S was clearly slowed in the presence of 100 
I~M cyclothiazide (Figure 5D). For wild-type GluR6, the 
time required for desensitization to reach 63% of maxi- 
mum for control responses to 1 mM kainate was 11.6 _+ 
1.3 ms (n = 13), with no change in the presence of cyclothi- 
azide (11.2 _ 1.2 ms; n = 11). For GluR6Q755S, the 
values were 25.5 _ 1.5 ms (n = 16) for control responses 
and 56.8 _+ 4.2 ms (n = 9) in the presence of cyclothiazide. 
However, other functional properties characteristic of 
GluR6, including a high affinity for kainate, lack of sensitiv- 
ity to AMPA, and pronounced block of desensitization by 
concanavalin A (Egebjerg et al., 1991; Partin et al., 1993) 
were maintained in GluR6Q755S (data not shown). 
To control for nonspecific effects resulting from muta- 
tions at position 750 in AMPA receptors, we introduced 
an alanine at position 750; for this mutant, potentiation by 
cyclothiazide was between those for GluR-Ai and GluR-Ao 
(data not shown), indicating that substitution with an amino 
acid other than serine or asparagine is not sufficient to 
prevent modulation by cyclothiazide. Further evidence for 
a critical role of residue 750 was obtained by mutating a 
second serine residue at position 760, which for GluR-A 
but not other AMPA receptor subunits (Figure 1) is ex- 
changed by alternative splicing from serine (flip) to aspara- 
gine (flop); in GluR-B, GiuR-C, or GluR-D both splice vari- 
ants encode an asparagine at the position homologous to 
$760 in GluR-A~. The mutation A~S760N behaved similarly 
to wild-type GluR-A~ when assayed in Xenopus oocytes 
for potentiation by cyclothiazide and for the kinetics of 
recovery from potentiation (data not shown). Thus, the 
effects on differential regulation by cyclothiazide of serine 
to asparagine exchange in GluR-A depend critically on 
the location of the altered site, and are restricted to posi- 
tion 750. 
Sensit ivity to Cyclothiaz ide in Heteromeric  
AMPA Receptors 
In heteromeric AMPA receptors assembled from wild-type 
GluR-A and GluR-B, the flip splice forms are dominant for 
regulating sensitivity to block of desensitization by cyclo- 
thiazide (Partin et al., 1994). To determine whether the 
single amino acid residue at position 750, which controls 
sensitivity to cyclothiazide in homomeric receptors assem- 
bled from GluR-A, is sufficient to regulate desensitization 
of responses for heteromeric AMPA receptors, we as- 
sayed the sensitivity to cyclothiazide of heteromeric recep- 
tors for which an asparagine to serine exchange was made 
in either the GluR-Ao or GluR-Bo subunits (Figure 6). 
Cyclothiazide produced pronounced attenuation of desen- 
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Figure 6. For Heteromeric AMPA Receptors, aSerine Residue at the 
Ser/Asn Site in either GluR-A or GluR-B Is Sufficient to Confer Strong 
Sensitivity to Attenuation of Desensitization by Cyclothiazide 
For each subunit combination, the left-hand trace shows a control 
response to 1 mM glutamate (closed bars); traces on the right were 
recorded uring application of 100 pM cyclothiazide (ope'n bars). Con- 
trol responses to glutamate are shown on a 4-times expanded time 
scale and are normalized to the peak amplitude of responses recorded 
in the presence of cyclothiazide. 
(A) A 50-fold slowing of the rate of onset of desensitization by cyclothia- 
zide for wild-type hoB°, but with pronounced esensitization atequi- 
librium. 
(B and C) Strong attenuation ofdesensitization by cyclothiazide for 
the combinations hoN750SBo and hoBoN754S. 
(D) ResUlts for ho[oi]Bo[oi]. When the C-terminal set of 4 amino acids 
was exchanged from the flop (GGGD) to the flip (KDSG) version, there 
was pronounced esensitization i  the presence of cyclothiazide, but 
with a rate of onset slowed 50-fold compared with control, similar to 
results obtained for wild-type hoBo. 
(E and F) Summaries of equilibrium desensitization a d poteniiation 
of responses to 1 mM glutamate, both recorded in the presence of 
100 p_M cyclothiazide for 5-7 293 cells per subunit (bars show mean 
± SEM). 
sitization evoked by glutamate for both AoN750SBo (100 
p.M cyclothiazide; 27.6% _.+ 6.2% desensitization; n = 7) 
and AoBoN754S (100 I~M cyclothiazide; 14.3% + 0.6% 
desensitization; n = 5), indicating that in heteromeric re- 
ceptors a serine residue on either the GluR-A or GluR-B 
subunit is sufficient o confer high sensitivity to cyclothia- 
zide. Control responses to I mM glutamate were not influ- 
enced by these mutations, with 95.9% _+ 1.0% desensi- 
tization, "~des = 5.0 _ 0.19 ms for AoN750SBo, and 
95.9% _ 1,8% desensitization, ~es -- 4.9 -+ 0.40 ms for 
AoBoN754S. Although not verified experimentally, these 
results suggest that cyclothiazide would also strongly at- 
tenuate desensitization for receptors assembled from 
GluR-Ao and GluR-Bo subunits both containing an aspara- 
gine to serine mutation; in contrast, when the C-terminal 
set of 4 amino acids was exchanged from the flop (GGGD) 
to the flip (KDSG) version in both GluR-A and GluR-B sub- 
units, desensitization remained pronounced in the pres- 
ence of cyclothiazide (Figure 6). Control responses to 
glutamate for Ao[oi]Bo[oi] showed 96.3% __+ 1.1% desensi- 
tization, with 89.8% + 2.3% desensitization (n -- 6) in 
the presence of 100 I~M cyclothiazide and a rate of onset 
slowed 50-fold compared with control (~des control = 5.0 
_+ 0.47 ms; "~es cyclothiazide = 367 _ 39 ms), similar 
to results obtained for the wild-type combination AoBo (~des 
control = 3.6 __. 0.11 ms; "~des cyclothiazide = 324 _ 12 
ms; n = 7). 
In Heteromeric AMPA Receptors, Separate 
Functional Domains Control Sensitivity to 
Cyclothiazide and Equilibrium Amplitude of 
Responses to Kainate versus Glutamate 
For heteromeric AMPA receptors assembled from various 
combinations of the flip and flop forms of GluR-A and GluR-B, 
prior work reveals an 8-fold difference in the amplitude of 
equilibrium responses to maximally effective concentra- 
tions of kainate and glutamate for AiB~ compared with AoBo, 
with intermediate behavior observed for A~Bo and AoB~ 
(Sommer et al., 1990). Recent work suggests this reflects 
subunit-dependent differences in the extent of desensiti- 
zation of responses to glutamate (Mosbacher et al., 1994; 
Partin et al., 1994). Because the rapidity and extent of 
desensitization make accurate measurement of the peak 
amplitude of agonist responses at AMPA receptors techni- 
cally difficult, the effects of mutations in the flip/flop region 
were analyzed using the original approach of Kein&nen 
et al. (1990): comparing the amplitude of equilibrium re- 
sponses to 300 p.M kainate with those to 300 I~M gluta- 
mate. To assay changes in sensitivity to cyclothiazide, 
in the same experiments we measured the time for 63% 
recovery from potentiation of responses to kainate by 
cyclothiazide. The results of these experiments indicate 
that, compared with the site controlling sensitivity to 
cyctothiazide, additional residues in the flip/flop modules 
of heteromeric AMPA receptors determine the relative am- 
plitude of equilibrium responses to kainate versus gluta- 
mate (Figure 7). The amplitude ratio (kainate/glutamate) 
of responses for these agonists was highest for wild-type 
AoBo (27.1 _+ 0.7) and decreased approximately 3-fold 
upon exchange of asparagine to serine at positions 750 
and 754 in G lu R-A and G luR-B (10.4 _ 4.1), with a similar 
3-fold decrease upon exchange from GGGD to KDSG of 
the C-terminal set of 4 amino acids in both GluR-A and 
GluR-B (8.7 __+ 0.6), but remained below the value for A~B~ 
(2.5 __. 0.7). Results presented earlier for the heteromeric 
combinations AoBoN750S, AoN750SBo, and Ao[oi]Bo[oi] 
suggest that, since a serine residue in either the GluR-A 
or GluR-B subunit is sufficient to allow cyclothiazide to 
attenuate desensitization, a similar effect would occur for 
AoN750SBoN750S, Ao[ii]Bo[ii], and Ao[iii]Bo[iii]. The 20-fold 
slowing of the rate of recovery from potentiation by cyclo- 
thiazide observed for AoN750SBoN750S contrasts with the 
lack of effect observed for Ao[oi]Bo[oi], indicating that sepa- 
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Figure 7. The Relative Amplitude of Equilibrium Responses to Kai- 
nate and Glutamate Is Controlled by Amino Acids Additional to the 
Ser/Asn Site Regulating Sensitivity to Cyclothiazide 
(A) Superimposed responses to 300 p.M kainate (open bar, traces on 
left) recorded from 6 oocytes for heteromers generated either from 
wild-type AoBo or A~Bi or from mutants into which flip splice variant 
residues were progressively substituted inboth the G luR-A and GluR-B 
subunits, as indicated above the records; traces on the right show 
individual responses from the same oocytes to 300 t~M glutamate. The 
scale for glutamate responses is 2.5 times that for kainate; to allow 
comparison between oocytes, responses to kainate are scaled to the 
same size; the scale bar applies to responses recorded for AoBo (scale 
factors for other subunit combinations ranged from 0.9 to 6.4). 
(B) Summary of the subunit dependence of the relative amplitude of 
responses to 300 p.M kainate and 300 pM glutamate recorded from 
8-15 oocytes (mean _+ SEM) per subunit combination for heteromers, 
and for comparison from 7 oocytes each for homomeric GluR-A. 
(C) Summary of measurements ofthe time required for 63% recovery 
from potentiation f responses to 300 p.M kainate by 300 p.M cyclothia- 
zide for the same subunit combinations. 
rate residues control allosteric regulation by cyclothiazide 
and the relative amplitude of responses to kainate and 
glutamate (Figure 7B). The times required for 63% recov- 
ery from potentiation were 5.6 ___ 0.7 s for AoBo, 95.9 + 
6.2 s for AoN750SBoN750S, 5.3 _ 0.5 s for Ao[oi]Bo[oi], 
and 113.5 _ 6.4 s for AiB~. 
The combined exchange of both asparagine to serine 
and the conserved set of C-terminal 4 amino acids in Ao[ii]- 
Bo[ii] produced a 5.4-fold increase in the relative amplitude 
of equilibrium responses to glutamate versus kainate. This 
was significantly (p < .05) lower than the 1 1-fold difference 
observed between wild-type AoBo and AiB~ (Figure 7A), 
even though the kinetics of recovery from potentiation by 
cyclothiazide were similar for these combinations (Figure 
7B). The additional exchange of residues at the N-terminal 
end of the flip/flop modules that differ between splice vari- 
ants in GluR-A and GluR-B fully restored the behavior of 
wild-type flip receptors; the relative amplitude of re- 
sponses to kainate versus glutamate was 2.8 _ 0.2 for 
Ao[iii]Bo[iii], with 104.4 _ 9.5 s required for 63% recovery 
from potentiation (these values are not significantly differ- 
ent from results obtained for wild-type A,B~). Although it 
has been shown that AMPA receptor responses evoked 
by kainate desensitize by approximately 30% (Patneau et 
al., 1993), responses to glutamate desensitize to a much 
greater extent (Table 1). Thus, in Figure 7A our superimpo- 
sition of responses to kainate reflects the assumption that 
subunit-specific hanges in the relative amplitude of re- 
sponses to glutamate occur because the mutations in the 
flip/flop module that alter desensitization do so to a greater 
extent for responses to glutamate than for kainate. Thus, 
amino acids that regulate recovery from potentiation by 
cyclothiazide of responses to kainate in heteromers gener- 
ated from GluR-A and GluR-B are also critical for attenua- 
tion of desensitization, but are not sufficient for determin- 
ing the relative amplitude of control responses to kainate 
versus glutamate. 
Discussion 
Recent experiments to determine the transmembrane to- 
pology of non-N-methyI-D-aspartate (NMDA) receptors, 
using insertional mutagenesis of glycosylation sites (Holl- 
mann et al., 1994) or antigenic epitopes (Bennett and Din- 
gledine, 1995), have resulted in topological models for 
AMPA receptors that place the flip/flop region extracellu- 
larly (but see also McGlade-McCulloh et al., 1993). Based 
on analysis of the agonist binding properties of AMPA and 
kainate receptor chimeras (Stern-Bach et al., 1994), a re- 
cent model for AMPA receptors places the flip/flop region 
in an extracellular domain labeled $2. Together with amino 
acids located in the N-terminal $1 domain, residues in $2 
are believed to form the agonist-binding site. According 
to this model, amino acids in the flip/flop module are not 
in close contact with agonist, consistent with our finding 
that the mutations generated for the present study did not 
affect the potency of kainate or the rate of onset of or 
extent of desensitization of control responses to glutamate 
(Table 1). The results of our experiments, combined with 
models based on studies with chimeric receptors, raise 
the possibility that part of the binding site for cyclothiazide 
in GtuR-A includes residue 750. Hence, although the flip 
and flop variants of AMPA receptors show differences in 
amino acid sequence at three separate areas (Figure 1), 
for homomeric receptors assembled from GluR-A, their 
strikingly different sensitivity to cyclothiazide can be fully 
explained by a single amino acid difference at position 
750; an identical conclusion can be reached for hetero- 
meric receptors assembled from GluR-A and GluR-B. Al- 
though we have not performed mutagenesis experiments 
for subunits other than GluR-A and GluR-B, we have con- 
firmed that homomeric receptors generated from GluR-Ci 
and GluR-D, also show marked attenuation of desensitiza- 
tion by cyclothiazide, identical to that observed for Glu R-A~, 
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whereas for GluR-Co and GluR-Do, desensitization re- 
mains pronounced in the presence of cyclothiazide, but 
with a greatly reduced rate of onset, similar to results ob- 
tained for GluR-Ao (data not shown) and further suggesting 
that results obtained for GluR-A and GluR-B mutants ex- 
tend to other AMPA receptor subunits. Finally, not only 
was sensitivity to cyclothiazide abolished in GluR-A by the 
substitution of Gin for Ser-750, a residue conserved in all 
cyclothiazide-insensitive kainate receptors, but the substi- 
tution of serine for glutamine conferred cyclothiazide sen- 
sitivity upon GluR6 (Figure 5). Together, these results pro- 
vide definitive evidence for a critical role of this site in 
regulating the selectivity of cyclothiazide. Our data further 
support the conclusions of Stern-Bach et al. (1994)--that 
the membrane topologies of AMPA- and kainate-preferring 
receptors share structural similarity--but do not provide 
definitive evidence whether the whole of the M3-M4 loop 
is extracellular, or whether an additional membrane- 
crossing region exists within this region (Roche et al., 
1994; Taverna et al., 1994). 
Structural models for glutamate receptors based on 
homology with lysine/arginine/ornithine-binding protein 
(LAOBP), for which crystal structures have been solved 
at atomic resolution for the ligand-bound and ligand-free 
states (Oh et al., 1993), suggest that Ser-750 will be lo- 
cated in a solvent-accessible a-helical region (O'Hara et 
al., 1993; Kuryatov et al., 1994; Stern-Bach et al., 1994). 
Of interest, helical wheel models for the flip/flop module 
and for the homologous region of LAOBP show similar 
features and place Ser-750 on one face of an amphipathic 
helix together with other polar residues, including Arg-739, 
which in GluR-B, GluR-C, and GluR-D is a site at which 
RNA editing introduces an arginine to glycine substitution, 
with effects on the extent of and kinetics of recovery from 
desensitization (Lomeli et al., 1994). High resolution struc- 
tural analysis, or photoaffinity labeling experiments, will 
ultimately be required to confirm that residues surrounding 
Ser-750 directly contribute to the binding of cyclothiazide 
to AMPA receptors, since it is not yet possible to exclude 
that the flip/flop module is involved in conformational tran- 
sitions underlying desensitization, with binding of cyclothi- 
azide to some other site acting via an allosteric effect. 
Our finding that, for heteromeric receptors assembled 
from GluR-Ao and GluR-Bo, the presence of a serine resi- 
due in either the GluR-A or GluR-B subunit confers high 
sensitivity to cyclothiazide, would be consistent with de- 
sensitization resulting from a concerted transition involv- 
ing all subunits, with the binding of cyclothiazide to even 
a single subunit blocking the conformational transition un- 
derlying desensitization. Consistent with this hypothesis, 
kinetic analysis of responses to cyclothiazide has revealed 
that for AoBo cyclothiazide does not slow the rate of onset 
of desensitization per se, but rather, that the slow onset 
of desensitization in the presence of cyclothiazide results 
from dissociation of cyclothiazide, and that receptors 
which have bound cyclothiazide are unable to desensitize 
(Patneau et al., 1994., Soc. Neurosci., abstract). 
Our analysis shows that the first documented functional 
difference for the flip and flop versions of heteremeric 
AM PA receptors (Sommer et al., 1990)--a lower amplitude 
of equilibrium responses to glutamate versus kainate for 
AoBo than for A~Bi--is not determined by the single amino 
acid that controls sensitivity to cyclothiazide. Rather, all 
of the conserved amino acids that differ between flip and 
flop splice variants must be exchanged to alter the relative 
amplitude of agonist responses to that seen for A~B~. Al- 
though the major part of this effect occurs upon exchange 
of the 5 amino acids conserved in all four AMPA receptor 
subunits, in GluR-B, GluR-C, and GluR-D the N-terminus 
of the alternatively spliced region contains an additional 
2 amino acid difference conserved between flip (ThrPro) 
and flop (AsnAla) splice variants, while for GluR-A there 
is only a single amino acid difference in this region (flip, 
GlyPro; flop, AsnPro). Exchange of these amino acids in 
GluR-A and GluR-B, in conjunction with the set of 5 amino 
acids conserved between flip and flop splice variants of 
all four AMPA receptor subunits, produced an additional 
small increase in relative amplitude of responses to gluta- 
mate, consistent with recent experiments which indicate 
that multiple regions in the flip/flop module of AMPA recep- 
tors must contribute to the regulation of desensitization 
(Mosbacher et al., 1994; Lomeli et al., 1994). 
Because cyclothiazide interferes with the process of de- 
sensitization, it is probable that high resolution analysis 
of responses to cyclothiazide recorded from subunit com- 
binations additional to those examined in the present 
study, including those for which RNA editing is known to 
regulate desensitization (Lomeli et al., 1994), will reveal 
differences in sensitivity to allosteric regulation of desensi- 
tization beyond those described here. Also, based on dif- 
ferences in the extent of desensitization of responses to 
glutamate for AMPA receptor subunits in which the site 
preceding the flip/flop module is in its edited (G) or uned- 
ited (R) form, it would be expected that the relative ampli- 
tude of responses to glutamate and kainate will also be 
altered by RNA editing. 
The experiments described here and in other studies 
(Partin et al., 1993, 1994) have been directed toward eluci- 
dating the structural requirements for allosteric regulation 
of non-NMDA receptors. Currently, no endogenous analog 
of cyclothiazide is known to be present in the brain, al- 
though it is known that for other receptors endogenous 
compounds such as neurosteroids modulate the activity 
of NMDA and 7-aminobutyric acid receptors (Wu et al., 
1991 ; Paul and Purdy, 1992; Bowlby, 1993). The provoca- 
tive suggestion that compounds acting as allosteric regu- 
lators of AMPA receptor activity improve performance in 
animal models of learning (Staubli et al., 1994; Nicoletti 
et al., 1992) requires further insight into the molecular iden- 
tity of the binding site for cyclothiazide; such studies could 
in turn lead to the discovery or design of novel drugs that 
may improve cognitive function. 
Experimental Procedures 
Mutagenesis 
Single and double amino acid substitutions within the flip/flop region 
were made by dut- ung- oligonucleotide-directed missense mutagene- 
sis (Bio-Rad Muta-Gene Phagemid/n Vitro Mutagenesis Kit [Version 
2]). Mutations were made using single-stranded DNA templates gener- 
ated in pBS. After mutagenesis, fragments encoding the mutated 
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amino acids were shuttled back into the appropriate glutamate recep- 
tor cDNAs in eukaryotic expression vectors (KeinSnen et al., 1990; 
Sommer et al., 1990; Schall et al., 1990), using BspEI-BspEI (nucleo- 
tides 1777-2320), ApaI-Mscl (nucleotides 251-2402), or BspEI-Mscl 
(nucleotides 1777-2402) fragments as appropriate. A~[io] was made 
in the eukaryotic expression vector by stepwise PCR mutagenesis, 
with 3' primers encoding the point mutations and overlapping the 
Eco47111 (nucleotide 2341) site. After subcloning into a eukaryotic ex- 
pression vector (Schall et al., 1990), all mutations were confirmed by 
double-stranded sequencing of CsCI gradient-purified DNA. Ao[oi], 
Bo[ii], Bo[N-S], and Bo[oi] were made in the laboratory of P. H. Seeburg. 
GluR6Q755S was constructed using overlapping PCR (Ultma polymer- 
ase; Perkin-Elrner, Foster City, CA), with flanking primers covering 
the unique EcoRV and Eco47111 sites in CMV GluR6(Q) and internal 
primers encoding the CAG to TCG mutation. After CsCI gradient purifi- 
cation of the plasmid encoding the mutation, the region that had under- 
gone PCR amplification was sequenced. 
Oocyte Electrophysiology 
Oocytes were surgically obtained from anesthetized, adult Xenopus 
laevis (Nasco) prepared as previously described (Partin et al., 1994). 
Nuclear DNA injections were performed, using 1-2 I~g/p-I homomeric 
cDNA or, for hetero-oligomeric ombinations, using a 1:5 ratio of 
GluR-A:GluR-B. Two-electrode voltage-clamp recordings were done 
2-6 days after injection. In some experiments, because of the large 
currents expressed (1-10 p.A), a virtual ground headstage was used 
to clamp the bath potential at ground. For these experiments, we used 
low-resistance agarose-cushion electrodes (Sch reibmayer et al., 1994) 
to prevent leakage of electrolyte. The oocytes were continuously per- 
fused with modified Barth's extracellular solution (88 mM NaCI, 1 mM 
KCI, 2.4 mM NaHCO3, 0.3 mM Ba(NO3)2, 0.41 rnM BaCI2, 0.82 mM 
MgCI2, 15 mM HEPES [pH 7.6]), to which was added kainate or gluta- 
mate (Sigma), with or without cyclothiazide (20 mM stock dissolved 
in dimethyl sulfoxide [DMSO]). Agonist responses were acquired by an 
ITC-16 interface (Instrutech Corporation) under control of the program 
Synapse (Synergistic Research Systems; available by anonymous 
FTP from Zippy.NIMH.NIH.GOV in the directory\pub\synapse) run- 
ning on a Macintosh llfx computer. Hetero-oligomer formation was 
assessed using leak-subtracted ramp I-Vs from -125 mV to +50 mV, 
calculating the slope conductance ratio G+~mv/G-6omv; only oocytes with 
ratios > 1:0 were used for analysis. 
Dose-response analysis was performed using close to maximally 
effective concentrations of either cyclothiazide or kainate as appro- 
priate (see Figure 2 and Figure 3). Responses were fit to the equation: 
I = ImaxI1/[1 + (ECs0/[ligand])°]l, 
where I~x is the response at a saturating concentration of ligand, EC~0 
is the concentration of ligand producing a half-maximal response, and 
n is the Hill coefficient. For kainate dose-response curves, to allow 
for correction of rundown, bracketing responses to a given concentra- 
tion of kainate were recorded at the beginning and end of the control 
dose-response run, then the dose-response curve for cyclothiazide 
plus kainate was collected, also with bracketing responses. A function 
describing the time course of rundown was fit to the bracketing re- 
sponses for each oocyte, and then the experimental responses were 
normalized to the interpolated control value. Datavalues are presented 
as mean _+ SEM. 
Expression of Recombinant Receptors in 293 Cells 
Human embryonic kidney 293 cells (ATCC CRL 1573) were maintained 
in MEM with Earle's salts, 2 mM L-glutamine, and 10% fetal bovine 
serum (5% CO2 at 37°C). Cultures were split upon reaching 70O/o - 
80% confluency and for transfection were plated at a density of 20,000 
cells per milliter onto plastic 35 mm dishes (Nunc). After 24 hr, vectors 
carrying cDNAs for AMPA receptor subunits were cotransfected with 
a vector for the cDNA of green fluorescent protein (GFP; gift of P. H. 
Seeburg) using the calcium~phosphate t chnique described by Chen 
and Okayama (1987). In each case, cDNA for GFP was present at a 
ratio of 1:4 of the total DNA (20-40 ~g/ml) added. For the expression 
of heteromeric receptors, cDNAs of GluR-A and GluR-B were 
transfected at a ratio of 1:4, respectively, to limit expression of homo- 
meric channels from GluR-A. In some experiments, cells were replated 
after transfection to optimize solution exchange during concentration 
jump experiments. 
ElectrOphysiological Analysis in 293 Cells 
Agonist-evoked currents (holding potential = -60 mV) were recorded 
from isolated~cells 40-72 hr after transfection using an Axopatch-200A 
amplifier (Axon Instruments) in whole-cell configuration, using GFP 
fluorescence (Chalfie et al., 1994) to identify transfected cells (450- 
490 nm excitation; 510 nm dichroic; 520 nm barrier). The acquisition 
and analysis of data were performed on a Macintosh Ilfx computer 
using the program Synapse (available by anonymous FTP from 
Zippy.NIMH.NIH.GOV in the directory\pub\synapse) to control an 
ITC-16 interface. The assembly of heteromeric receptors in individual 
cells was verified by determining the slope conductance ratio (G+eomv/ 
G somv) for I mM kainate in the presence of 100 p.M cyclothiazide. Only 
recordings from cells in which this ratio value was greater than 1 were 
accepted for analysis. The kinetics of onset of desensitization were 
fit using one exponential or the sum of two exponentials, with time 
constants and relative amplitudes indicated by T~e,, A~, "~2dBs, and A2. 
Extracellular ecording solution contained 145 mM NaCI, 5.4 rnM 
KCI, 1.8 mM CaCI2,1 mM MgCI2, 5 mM HEPES, and 0.01 mg/ml phenol 
red (pH 7.3; osmolarity, 305 mOsm). Thick- or thin-wall borosilicate 
glass pipettes with resistances of 2-5 MQ contained 135 mM CsCI, 
10 mM CsF, 0.5 mM CaCI2, 1 mM MgCI2, 10 mM HEPES, 2 mM Mg- 
ATP, and 5 mM Cs-BAPTA (pH 7.2; osmolarity, 305 mOsm). Agonists 
were dissolved in normal extracellular solution and applied using a 
stepper motor-based fast perfusion system (Vyklicky et al., 1990). 
Cyclothiazide was dissolved in DMSO at 20 mM before dilution with 
extracellular solution (final DMSO concentration after dilution was 
0.5% ). Salts, biochemicals, and excitatory amino acids were pur- 
chased from Aldrich, Diagnostic Chemicals, Molecular Probes, Sigma, 
and Tocris Neuramin. 
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